Clinical Trial Update: N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update describing Phase 2/Phase 3 evaluation of N-acetylcysteine in patients with heart failure and coexisting chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Bayside Health | Conditions: Heart Failure, Congestive, Kidney Failure, Chronic | Phase 2, Phase 3 | Status: UNKNOWN